The event is over. See you in the next one.
About this event
Particles in the visible and subvisible size range can appear in (bio)pharmaceutical samples and drug products during all stages of development and even after market approval. The presence of particles can indicate an insufficient stability of the active pharmaceutical ingredient or issues with the production process and can negatively influence the safety and efficacy of the medicine.
In this webinar we will talk about tools and methods for particle identification and characterization in biologics and gene and cell therapy drug products.
LEARNING OBJECTIVES
Coriolis Pharma is a globally operating contract research and development organization and one of the world leaders in formulation research and development of biopharmaceuticals including vaccines and ATMPs.